RU2020116968A - Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects - Google Patents

Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects Download PDF

Info

Publication number
RU2020116968A
RU2020116968A RU2020116968A RU2020116968A RU2020116968A RU 2020116968 A RU2020116968 A RU 2020116968A RU 2020116968 A RU2020116968 A RU 2020116968A RU 2020116968 A RU2020116968 A RU 2020116968A RU 2020116968 A RU2020116968 A RU 2020116968A
Authority
RU
Russia
Prior art keywords
anxiolytic
analgesic
antiaddictive
effects
molecular weight
Prior art date
Application number
RU2020116968A
Other languages
Russian (ru)
Other versions
RU2020116968A3 (en
RU2759023C2 (en
Inventor
Лариса Геннадьевна Колик
Анна Владимировна Надорова
Екатерина Михайловна Григоревских
Нелли Михайловна Сазонова
Татьяна Александровна Гудашева
Андрей Дмитриевич Дурнев
Original Assignee
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" filed Critical Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"
Priority to RU2020116968A priority Critical patent/RU2759023C2/en
Publication of RU2020116968A3 publication Critical patent/RU2020116968A3/ru
Publication of RU2020116968A publication Critical patent/RU2020116968A/en
Application granted granted Critical
Publication of RU2759023C2 publication Critical patent/RU2759023C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Применение гексаметилендиамида бис-(-N-гексаноил-L-серил-L-лизина) в качестве анальгетического, анксиолитического и антиаддиктивного средства.The use of bis - (- N-hexanoyl-L-seryl-L-lysine) hexamethylenediamide as an analgesic, anxiolytic and anti-addictive agent.
RU2020116968A 2020-04-29 2020-04-29 Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects RU2759023C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2020116968A RU2759023C2 (en) 2020-04-29 2020-04-29 Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2020116968A RU2759023C2 (en) 2020-04-29 2020-04-29 Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects

Publications (3)

Publication Number Publication Date
RU2020116968A3 RU2020116968A3 (en) 2021-10-29
RU2020116968A true RU2020116968A (en) 2021-10-29
RU2759023C2 RU2759023C2 (en) 2021-11-08

Family

ID=78466344

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020116968A RU2759023C2 (en) 2020-04-29 2020-04-29 Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects

Country Status (1)

Country Link
RU (1) RU2759023C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678203C2 (en) * 2017-05-30 2019-01-24 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Pharmaceutical composition of neuroprotective action for parenteral application on basis of hexamethylenediamine bis-(n-monosuccinyl-l-glutamil-l-lysine) in lyophilized dosage form
RU2701557C2 (en) * 2017-11-24 2019-09-30 Общество С Ограниченной Ответственностью "Инновационные Фармакологические Разработки" (Ооо "Ифар") 1,4-benzodiazepin-2-one derivatives and use thereof
RU2711968C1 (en) * 2018-11-22 2020-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" Analgesic agent
RU2700576C1 (en) * 2019-05-07 2019-09-18 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Anxiolytic agent
RU2707301C1 (en) * 2019-05-17 2019-11-26 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Low-molecular mimetic bdnf as an agent for treating opioid dependence

Also Published As

Publication number Publication date
RU2020116968A3 (en) 2021-10-29
RU2759023C2 (en) 2021-11-08

Similar Documents

Publication Publication Date Title
CO6331425A2 (en) COMPOSITIONS THAT INCLUDE N- (3,4-DIFLUORO-2- (2-FLUORO-4-IODOFENILAMINO) 6-METOXIFENIL) -1- (2,3-DIHYDROXIPROXIPROPIL) CICLOPROPAN-1-SULFAMIDA
CY1116463T1 (en) Combination therapy for the therapeutic treatment of Protein Deficiency Disorders
BR112015019064A8 (en) use of a composition comprising nanoparticles comprising paclitaxel and an albumin for the treatment of melanoma and kit
BR112015025711A8 (en) use of ibrutinib and pharmaceutical composition comprising ibrutinib and an anticancer agent
BR112015010059A2 (en) adjuvant therapy with the tec family kinase inhibitor
EA201591403A1 (en) SPIROLACTAM NMDA RECEPTOR MODULATORS AND THEIR APPLICATION
EA201591405A1 (en) SPIROLACTAM NMDA-RECEPTOR MODULATORS AND THEIR APPLICATION
EA201892657A1 (en) SPYROLACTAM MODULATORS OF THE NMDA-RECEPTOR AND THEIR APPLICATION
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
CO6280406A2 (en) ANTI-MICROBIAL POLYPEPTIDES FOR USE IN THE TREATMENT OF MICROBIAL DISORDERS
TR200801336T1 (en) Compositions and methods for the preparation of drugs with increased stability to poor water solubility.
MX2021004999A (en) Administration of butyrate, bete-hydroxybutyrate, cannabidiol, and related compounds in humans.
EA201170227A1 (en) ИМИДАЗОЛКАРБОКСАМИДЫ
EA201591402A1 (en) SPIROLACTAM NMDA-RECEPTOR MODULATORS AND THEIR APPLICATION
CY1121628T1 (en) SALTS IT AND METHODS OF USE
MX2023001292A (en) Conjugated hepcidin mimetics.
TR200806298A2 (en) Pharmaceutical formulation
EA201990425A1 (en) SPIRO-LACTAM AND BIS-SPIRO-LACTAM MODULATORS OF THE NMDA RECEPTOR AND THEIR APPLICATION
CY1112121T1 (en) Derivatives of 1,2,3,4-tetrahydropyrrolo- [1,2-a] -pyrazine-6-carboxamides and 2,3,4,5-tetrahydropyrrolo- (1,2-a) -diazepine-7-carbamide , THEIR PREPARATION AND THEIR APPLICATION TO THERAPEUTIC EDUCATION
EA200970127A1 (en) MODULATOR OF GLUCOCORTICOSTEROID RECEPTORS AND METHODS OF ITS APPLICATION
EA202192047A1 (en) COMPOUNDS AND THEIR APPLICATIONS
CL2012003119A1 (en) Pharmaceutical composition for injection that compensates for an aqueous solution of ibuprofen and trometamol, in which the concentration of ibuprofen is between 2 and 6 mg / ml, the concentration of trometamol is between 1.8 and 5.8 mg / ml, and the pH is between 7.0 and 9.5; and its use for the treatment of pain, inflammation or fever.
RU2020116968A (en) Low molecular weight mimetic of brain neurotrophic factor with analgesic, anxiolytic and antiaddictive effects
CL2009000257A1 (en) Use of 1,3-substituted imidazolines and their physiologically compatible salts for the treatment of metabolic syndrome.